Articles tagged with "ACR Convergence 2021"

Early Data on Novel MK2 Inhibitor to Treat Inflammatory Diseases Promising

June 9, 2022 • By Michele B. Kaufman, PharmD, BCGP

Medication Preferences & Current Practices for PsA

May 11, 2022 • By Michele B. Kaufman, PharmD, BCGP

Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus

May 5, 2022 • By Michele B. Kaufman, PharmD, BCGP

Pre-Eclampsia Risk & Rheumatic Disease

April 21, 2022 • By Michele B. Kaufman, PharmD, BCGP

Improving Bone Mineral Density: Risedronate vs. Denosumab

March 2, 2022 • By Michele B. Kaufman, PharmD, BCGP

Diet & Gout Research Presented at ACR Convergence 2021

February 9, 2022 • By Keri Losavio

Highlights from ACR Convergence’s Late-Breaking Abstracts

February 2, 2022 • By Samantha C. Shapiro, MD

How to Differentiate Between & Manage Hypereosinophilic Syndromes & EGPA

February 2, 2022 • By Samantha C. Shapiro, MD

Multidisciplinary Guidance for Pulmonary Disease in Sjögren’s Syndrome

February 2, 2022 • By Samantha C. Shapiro, MD

How Do Axial SpA & PsA with Axial Involvement Differ?

February 2, 2022 • By Samantha C. Shapiro, MD

1
2
3
…
7
Next Page »